| ABUS |    | Arbutus Biopharma Corporation - Common Stock | | | 11.06% 11.06% 0 | | + Biopharma, Medicine, Hepatitis
Last highlighted: #ABUS SEC report: Arbutus Biopharma Corp Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Arbutus Biopharma Corp -- SEC File Number 211148337 | + My List |
| ACER | | Acer Therapeutics Inc. - Common Stock | | | 4% down 14.84% -10.84 | | + Medicine, Biopharma
| + My List |
| ACIU | | AC Immune SA - Common Stock | | | 9.93% 9.93% 0 | | + Disease: Neurology/Alzheimer/Parkinson's, Biopharma, Country: Switzerland
Last highlighted: #ACIU SEC report: AC Immune SA Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by AC Immune SA -- SEC File Number 211142337 | + My List |
| ACRS | | Aclaris Therapeutics, Inc. - Common Stock | | | -2.38% down 8.55% -10.93 | | + Immunology, Biopharma, Medicine
Last highlighted: #ACRS SEC report: Aclaris Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Aclaris Therapeutics, Inc. -- SEC File Number | + My List |
| ADIL | | Adial Pharmaceuticals, Inc - Common Stock | | | -8.11% -8.11% 0 | | + Biopharma, Disease: Addictions
- Alcohol
| + My List |
| ADMP | | Adamis Pharmaceuticals Corporation - Common Stock | | | 0 | | + Respiratory therapies / Pulmanory, Medicine, Biopharma
| + My List |
| AEZS | | Aeterna Zentaris Inc. - Common Stock | | | 0 | | + Medicine, Disease: Endocrine disease, Biopharma
| + My List |
| ALIM | | Alimera Sciences, Inc. - Common Stock | | | -6.95% up -7.47% 0.52 | | + Disease: Eye , Biopharma, Medicine
| + My List |
| ALRN | | Aileron Therapeutics, Inc. - Common Stock | | | 0 | | + Cancer fight, Medicine, Biopharma
| + My List |
| ALT | | Altimmune, Inc. - Common Stock | | | -6.86% up -7.28% 0.42 | | + Immunology, Biopharma, Medicine
Last highlighted: #ALT SEC report: Altimmune, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Altimmune, Inc. -- SEC File Number | + My List |
| ANCN | | Anchiano Therapeutics Ltd. - American Depositary Shares | | | 0.00% 0 | | + Cancer fight, Biopharma, Medicine, Country: Israel
| + My List |
| ARTL | | Artelo Biosciences, Inc. - Common Stock | | | 0 | | + Biopharma, Medicine
| + My List |
| ARWR | | Arrowhead Pharmaceuticals, Inc. - Common Stock | | | 4.1% down 8.1% -4 | | + Biopharma, RNA, Medicine
Last highlighted: #ARWR SEC report: ARROWHEAD PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARROWHEAD PHARMACEUTICALS, INC. -- SEC File Number 211148133 | + My List |
| ASLN | | ASLAN Pharmaceuticals Limited - American Depositary Shares | | | 0 | | + Country: Singapore, Pharmaceutical , Biopharma, Immunology, Medicine
Last highlighted: $ASLN / ASLAN Pharmaceuticals files form 6-K https://t.co/rm8jqdBSsq | + My List |
| ASMB | | Assembly Biosciences, Inc. - Common Stock | | | 8.78% 8.78% 0 | | + Disease: Infectious, Medicine, Biopharma
| + My List |
| ATNX | | Athenex, Inc. - Common Stock | | | 0 | | + Cancer fight, Biopharma, Covid (fighting)
Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc.
https://t.co/1k3SCVGjG9
30 seconds delayed. | + My List |
| AVIR | | Atea Pharmaceuticals, Inc. - common stock | | | 4.02% down 10.79% -6.77 | | + Biopharma
Last highlighted: $AVIR Aviragen Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/JOpVDsaGT1 | + My List |
| AZRX | | AzurRx BioPharma, Inc. - Common Stock | | | 0.00% 0 | | + Biopharma, Medicine, Disease: Gastrointestinal
Last highlighted: #AZRX SEC report: AzurRx BioPharma, Inc. Current report, item 5.02
SEC Filing Form 8-K filed by AzurRx BioPharma, Inc. -- SEC File Number 211083480 | + My List |
| BDSX | | Biodesix, Inc. - Common Stock | | | -11.58% -11.58% 0 | | + Biopharma, Medicine, Diagnosing, Disease: Lung
Last highlighted: A Form 8-K [Press/News Current Report] filing has been made with the SEC: $BDSX BIODESIX INC https://t.co/b5COJsaVls | + My List |
| BLCM | | Bellicum Pharmaceuticals, Inc. - Common Stock | | | 1.92% down 11.27% -9.35 | | + Biopharma, Medicine, Immunology
Last highlighted: #BLCM SEC report: BELLICUM PHARMACEUTICALS, INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by BELLICUM PHARMACEUTICALS, INC -- SEC File Number | + My List |
| BNTC | | Benitec Biopharma Inc. - Common Stock | | | -10.74% -10.74% 0 | | + Biopharma, Biotechnology, RNA, Medicine, Gene and cell
Last highlighted: Form 8-K: Regulation FD Disclosure. On February 24, 2021, Benitec Biopharma issued a presentation on the results of the interim analysis.. $BNTC https://t.co/mayyXsnb9Q | + My List |
| BTAI | | BioXcel Therapeutics, Inc. - Common Stock | | | -0.6% down 12.29% -12.89 | | + Medicine, Immunology, Artificial Intelligence, Biopharma
| + My List |
| BVXV | | BiondVax Pharmaceuticals Ltd. - American Depositary Shares | | | 2.56% up -14.18% 16.74 | | + Biopharma, Medicine, Disease: Infectious
| + My List |
| BXRX | | Baudax Bio, Inc. - Common stock | | | up -10% 10 | | + Surgery, Medicine, Biopharma
| + My List |
| BYSI | | BeyondSpring, Inc. - Ordinary Shares | | | 6.61% up -7.8% 14.41 | | + Cancer fight, Biopharma, Medicine, Immunology
Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR | + My List |
| CBIO | | Catalyst Biosciences, Inc. - Common Stock | | | 0 | | + Biopharma, Medicine
Last highlighted: #CBIO SEC report: CATALYST BIOSCIENCES, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by CATALYST BIOSCIENCES, INC. -- SEC File Number 211147291 | + My List |
| CCXI | | ChemoCentryx, Inc. - Common Stock | | | -0.78% down 7.43% -8.21 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01 | + My List |
| CDAK | | Codiak BioSciences, Inc. - Common Stock | | | 1.92% up -8.8% 10.72 | | + Medicine, Biopharma
| + My List |
| CDNA | | CareDx, Inc. - Common Stock | | | -2.67% down 8.35% -11.02 | | + Medicine, Biopharma, Transplant
Last highlighted: #CDNA SEC report: CareDx, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by CareDx, Inc. -- SEC File Number | + My List |
| CHMA | | Chiasma, Inc. - Common Stock | | | 0.00% 0 | | + Biopharma, Medicine
Last highlighted: $AMYT 6-K Amryt Pharma (5 May, 8:45am)
📰 Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
https://t.co/30R4PU1D1d
#AMYT #6K #AmrytPharma #News | + My List |
| CLLS | | Cellectis S.A. - American Depositary Shares | | | -8.15% -8.15% 0 | | + Biopharma, Medicine, Cancer fight
| + My List |
| CLRB | | Cellectar Biosciences, Inc. - Common Stock | | | 0 | | + Medicine, Biopharma, Cancer fight
Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932 | + My List |
| CLSD | | Clearside Biomedical, Inc. - Common Stock | | | -7.14% up -9.09% 1.95 | | + Disease: Eye , Medicine, Biopharma
| + My List |
| CNCE | | Concert Pharmaceuticals, Inc. - Common Stock | | | 2.28% down 7.97% -5.69 | | + Biopharma, Medicine
| + My List |
| CTMX | | CytomX Therapeutics, Inc. - Common Stock | | | 0.56% down 7.41% -6.85 | | + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
| + My List |
| CUE | | Cue Biopharma, Inc. - Common Stock | | | -1.98% up -14.15% 12.17 | | + Biopharma, Immunology, Cancer fight
| + My List |
| CVAC | | CureVac N.V. - Ordinary Shares | | | -7.42% down -7.36% -0.06 | | + Country: Germany, RNA, Medicine, Biopharma
| + My List |
| CYCC | | Cyclacel Pharmaceuticals, Inc. - Common Stock | | | 2.21% down 7.75% -5.54 | | + Biotechnology, Biopharma, Pharmaceutical , Medicine, Gene and cell
- Bad infrastructure
| + My List |
| CYCCP | | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | | | down 21.19% -21.19 | | + Cancer fight, Medicine, Biopharma
Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c | + My List |
| DBVT | | DBV Technologies S.A. - American Depositary Shares | | | 1.69% up -7.26% 8.95 | | + Immunology, Biopharma, Medicine
Last highlighted: #DBVT SEC report: DBV Technologies S.A. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by DBV Technologies S.A. -- SEC File Number 211136660 | + My List |
| DMAC | | DiaMedica Therapeutics Inc. - Common Stock | | | -8.8% -8.8% 0 | | + Biopharma, Disease: Kidney, Medicine, Disease: Acute ischemic stroke (AIS)
| + My List |
| DRNA | | Dicerna Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Biopharma, Pharmaceutical , RNA, Medicine
Last highlighted: $DRNA 📜 Dicerna Pharmaceuticals, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
https://t.co/pVex4DfvFC
30s delayed. | + My List |
| DRRX | | DURECT Corporation - Common Stock | | | 0 | | + Biopharma, Disease: Liver, Medicine
Last highlighted: $DRRX New Form 8-K for DURECT Corporation
From our Stock News Alerts App | + My List |
| DVAX | | Dynavax Technologies Corporation - Common Stock | | | 1.58% down 9.55% -7.97 | | + Immunology, Biology, Biopharma, Medicine, Vaccines
Last highlighted: #DVAX SEC report: DYNAVAX TECHNOLOGIES CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by DYNAVAX TECHNOLOGIES CORP -- SEC File Number | + My List |
| DYAI | | Dyadic International, Inc. - Common Stock | | | -7.39% -7.39% 0 | | + Medicine, Biopharma, Pharmaceutical
| + My List |
| EDSA | | Edesa Biotech, Inc. - Common Shares | | | 2.7% up -7.54% 10.24 | | + Medicine, Biopharma, Immunology
| + My List |
| EIGR | | Eiger BioPharmaceuticals, Inc. - Common Stock | | | up -8.19% 8.19 | | + Medicine, Biopharma
Last highlighted: #EIGR SEC report: Eiger BioPharmaceuticals, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Eiger BioPharmaceuticals, Inc. -- SEC File Number 211148434 | + My List |
| ELOX | | Eloxx Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Biopharma, Medicine, RNA
| + My List |
| ETNB | | 89bio, Inc. - Common Stock | | | 5.23% down 7.32% -2.09 | | + Biopharma, Disease: Liver, Medicine
| + My List |
| EYEN | | Eyenovia, Inc. - Common Stock | | | 0.99% up -7.42% 8.41 | | + Medicine, Biopharma
Last highlighted: #EYEN SEC report: EYENOVIA, INC. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by EYENOVIA, INC. -- SEC File Number | + My List |
| EYPT | | EyePoint Pharmaceuticals, Inc. - Common Stock | | | 5.17% up -9.76% 14.93 | | + Pharmaceutical , Disease: Eye , Medicine, Biopharma
Last highlighted: #EYPT SEC report: EyePoint Pharmaceuticals, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by EyePoint Pharmaceuticals, Inc. -- SEC File Number 211142305 | + My List |
| FBIO | | Fortress Biotech, Inc. - Common Stock | | | -6.73% up -8.65% 1.92 | | + Pharmaceutical , Biopharma, Biotechnology, Medicine
| + My List |
| FBIOP | | Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | | | 0.52% 0.52% 0 | | + Medicine, Biotechnology, Biopharma
| + My List |
| FBRX | | Forte Biosciences, Inc. - Common Stock | | | -4.27% down 14.68% -18.95 | | + Skin, Medicine, Disease: Infectious, Biopharma
| + My List |
| FLXN | | Flexion Therapeutics, Inc. - Common Stock | | | 0.00% 0 | | + Biopharma, Medicine, Disease: Musculoskeletal
| + My List |
| FOLD | | Amicus Therapeutics, Inc. - Common Stock | | | 0.67% down 16.43% -15.76 | | + Biopharma, Medicine
Last highlighted: #FOLD SEC report: AMICUS THERAPEUTICS, INC. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by AMICUS THERAPEUTICS, INC. -- SEC File Number 211148245 | + My List |
| FWP | | Forward Pharma A/S - American Depositary Shares | | | -6.96% up -8% 1.04 | | + Country: Denmark, Biopharma, Disease: Neurology/Alzheimer/Parkinson's
| + My List |
| GLMD | | Galmed Pharmaceuticals Ltd. - Ordinary Shares | | | 0 | | + Disease: Liver, Biopharma, Country: Israel, Medicine
Last highlighted: Galmed Pharmaceuticals Ltd current quarter revenue growth YoY of 96.40% ranked 256 out of 5424 companies in our database.
https://t.co/R7UW3RpPpw $GLMD
🚀🚀🚀🚀🚀 https://t.co/HVbvEgerWf | + My List |
| GLSI | | Greenwich LifeSciences, Inc. - Common stock | | | -1.69% up -12.57% 10.88 | | + Medicine, Biopharma, Cancer fight, Immunology
| + My List |
| GNFT | | GENFIT S.A. - American Depositary Shares | | | -2.75% down 25% -27.75 | | + Biopharma, Disease: Liver, Medicine
| + My List |
| HGEN | | Humanigen, Inc. - Common Stock | | | -1.93% up -9.18% 7.25 | | + Biopharma, Immunology, Cancer fight, Medicine
Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187 | + My List |
| HOTH | | Hoth Therapeutics, Inc. - Common Stock | | | 0 | | + Medicine, Biopharma, Skin
| + My List |
| ICPT | | Intercept Pharmaceuticals, Inc. - Common Stock | | | 0.48% up -9.64% 10.12 | | + Pharmaceutical , Medicine, Biopharma, Disease: Liver
Last highlighted: #ICPT SEC report: INTERCEPT PHARMACEUTICALS, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by INTERCEPT PHARMACEUTICALS, INC. -- SEC File Number | + My List |
| IMAB | | I-MAB - American Depositary Shares | | | -1.31% -1.31% 0 | | + Country: China, Biopharma, Medicine
Last highlighted: $IMAB 📜 SEC Form 6-K filed by I-MAB
https://t.co/B5768Avydp
#majorpharmaceuticals #healthcare | + My List |
| IMRN | | Immuron Limited - American Depositary Shares | | | 5.86% 5.86% 0 | | + Biotechnology, Country: Australia, Biopharma, Medicine
Last highlighted: $IMRN 📜 SEC Form 6-K filed by Immuron Limited
https://t.co/xsrBOQcQ0a | + My List |
| IMV | | IMV Inc. - Common Shares | | | up -11.43% 11.43 | | + Immunology, Medicine, Country: Canada, Covid (fighting), Biopharma
Last highlighted: #IMV SEC report: IMV Inc. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by IMV Inc. -- SEC File Number 211138178 | + My List |
| INSM | | Insmed, Inc. - Common Stock | | | -4.83% down 7.02% -11.85 | | + Biopharma, Medicine
| + My List |
| ISEE | | IVERIC bio, Inc. - Common Stock | | | -3.37% up -10.49% 7.12 | | + Medicine, Biopharma
Last highlighted: #ISEE SEC report: IVERIC bio, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IVERIC bio, Inc. -- SEC File Number 211142256 | + My List |
| ITOS | | iTeos Therapeutics, Inc. - Common Stock | | | -8.59% -8.59% 0 | | + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine
Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
https://t.co/fsH6i8bthL
15s delayed. | + My List |
| JAGX | | Jaguar Health, Inc. - Common Stock | | | 0 | | + Medicine, Biopharma, Agritech
| + My List |
| KALA | | Kala Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Disease: Eye , Disease: Gastrointestinal, Medicine, Biopharma
| + My List |
| KIN | | Kindred Biosciences, Inc. - Common Stock | | | 45.43% down 45.74% -0.31 | | + Animals, Biopharma, Biotechnology, Medicine, Pets
Last highlighted: #KIN SEC report: Kindred Biosciences, Inc. Definitive proxy statement relating to merger or acquisition
SEC Filing Form DEFM14A filed by Kindred Biosciences, Inc. -- SEC File Number 211102924 | + My List |
| KMDA | | Kamada Ltd. - Ordinary Shares | | | -3.52% -3.52% 0 | | + Biopharma, Pharmaceutical , Medicine
Last highlighted: #KMDA SEC report: KAMADA LTD Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by KAMADA LTD -- SEC File Number 211161938 | + My List |
| KNSA | | Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock | | | -0.37% up -7.06% 6.69 | | + Pharmaceutical , Biopharma, Medicine
Last highlighted: #KNSA SEC report: Kiniksa Pharmaceuticals, Ltd. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kiniksa Pharmaceuticals, Ltd. -- SEC File Number 211138062 | + My List |
| KOD | | Kodiak Sciences Inc - Common Stock | | | 8.11% 8.11% 0 | | + Biopharma, Disease: Eye , Medicine
| + My List |
| KRBP | | Kiromic BioPharma, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Immunology, Medicine
Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals | + My List |
| KROS | | Keros Therapeutics, Inc. - common stock | | | -12.04% -12.04% 0 | | + Biopharma, Medicine, Hematologic and musculoskeletal disorders
Last highlighted: #KROS SEC report: Keros Therapeutics, Inc. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Keros Therapeutics, Inc. -- SEC File Number 211148197 | + My List |
| KYMR | | Kymera Therapeutics, Inc. - Common Stock | | | -7.18% -7.18% 0 | | + Biopharma, Medicine
Last highlighted: #KYMR SEC report: Kymera Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Kymera Therapeutics, Inc. -- SEC File Number | + My List |
| LJPC | | La Jolla Pharmaceutical Company - Common Stock | | | -4.9% down 8.77% -13.67 | | + Medicine, Biopharma
Last highlighted: #LJPC SEC report: LA JOLLA PHARMACEUTICAL CO Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by LA JOLLA PHARMACEUTICAL CO -- SEC File Number | + My List |
| MDWD | | MediWound Ltd. - Ordinary Shares | | | -1.05% up -7.98% 6.93 | | + Biopharma
| + My List |
| MITO | | Stealth BioTherapeutics Corp. - American Depositary Shares | | | 0 | | + Medicine, Biopharma, Disease: Eye
| + My List |
| MNPR | | Monopar Therapeutics Inc. - Common Stock | | | -4.48% down 9.19% -13.67 | | + Cancer fight, Medicine, Biopharma
Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054 | + My List |
| MOR | | MorphoSys AG - American Depositary Shares | | | -9.41% -9.41% 0 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
| + My List |
| MREO | | Mereo BioPharma Group plc - American Depositary Shares | | | 0 | | + Biopharma, Cancer fight, Country: Greate Britain
Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904 | + My List |
| NGM | | NGM Biopharmaceuticals, Inc. - Common Stock | | | -1.11% -1.11% 0 | | + Biopharma, Medicine
Last highlighted: $NGM 📜 NGM Biopharmaceuticals, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
https://t.co/NbDnNxMZQc
#majorpharmaceuticals #healthcare | + My List |
| NMTR | | 9 Meters Biopharma, Inc. - Common Stock | | | 0 | | + Biopharma, Medicine, Disease: Bowel syndrome, Disease: Celiac
Last highlighted: #NMTR SEC report: 9 METERS BIOPHARMA, INC. Current report, items 1.01, 2.01, 8.01, and 9.01
SEC Filing Form 8-K filed by 9 METERS BIOPHARMA, INC. -- SEC File Number 211096936 | + My List |
| NTEC | | Intec Pharma Ltd. - Ordinary Shares | | | 0.00% 0 | | + Biopharma, Medicine, Cannabis
| + My List |
| NTLA | | Intellia Therapeutics, Inc. - Common Stock | | | -4.32% down 10.42% -14.74 | | + Medicine, Gene and cell, Biotechnology, Biopharma
| + My List |
| OCUP | | Ocuphire Pharma, Inc. - Common Stock | | | -4.07% -4.07% 0 | | + Disease: Eye , Biopharma, Medicine, Pharmaceutical
Last highlighted: $OCUP 📜 Ocuphire Pharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
https://t.co/xMAN0ucl8b
15s delayed. | + My List |
| OMER | | Omeros Corporation - Common Stock | | | 3.56% down 17.06% -13.5 | | + Biopharma, Biotechnology, Medicine
Last highlighted: #OMER SEC report: OMEROS CORP Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by OMEROS CORP -- SEC File Number | + My List |
| OSMT | | Osmotica Pharmaceuticals plc - Ordinary Shares | | | 0.00% 0 | | + Pharmaceutical , Women Health, Biopharma
| + My List |
| OTLK | | Outlook Therapeutics, Inc. - Common Stock | | | 1.27% down 12.5% -11.23 | | + Disease: Eye , Biopharma, Medicine
Last highlighted: #OTLK SEC report: Outlook Therapeutics, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by Outlook Therapeutics, Inc. -- SEC File Number | + My List |
| PGEN | | Precigen, Inc. - Common Stock | | | -5.19% down 8% -13.19 | | + Biopharma, Gene and cell, Medicine
Last highlighted: #PGEN SEC report: PRECIGEN, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PRECIGEN, INC. -- SEC File Number | + My List |
| PIRS | | Pieris Pharmaceuticals, Inc. - Common Stock | | | -1.14% down 7.06% -8.2 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight
Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334 | + My List |
| PLRX | | Pliant Therapeutics, Inc. - Common Stock | | | -27.98% -27.98% 0 | | + Biopharma, Medicine
| + My List |
| PRAX | | Praxis Precision Medicines, Inc. - Common Stock | | | 4.38% down 12.62% -8.24 | | + Biopharma, Gene and cell, Disease: Central nervous system (CNS), Medicine
Last highlighted: Research Analysts Set Expectations for Praxis Precision Medicines, Inc.’s Q1 2022 Earnings $PRAX https://t.co/u6zv6m9Tyz #markets | + My List |
| PRTK | | Paratek Pharmaceuticals, Inc. - Common Stock | | | 5.26% down 8.33% -3.07 | | + Pharmaceutical , Biopharma, Medicine, Life Sciences
| + My List |
| RGLS | | Regulus Therapeutics Inc. - Common Stock | | | 0 | | + RNA, Biopharma, Medicine
| + My List |
| RZLT | | Rezolute, Inc. - Common Stock | | | -14.37% -14.37% 0 | | + Biopharma, Medicine, Disease: Hypoglycemia
Last highlighted: #RZLT SEC report: Rezolute, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Rezolute, Inc. -- SEC File Number 211161853 | + My List |
| SAVA | | Cassava Sciences, Inc. - Common Stock | | | -2.24% down 7.67% -9.91 | | + Disease: Neurology/Alzheimer/Parkinson's, Medicine, Biopharma
| + My List |
| SNSS | | Sunesis Pharmaceuticals, Inc. - Common Stock | | | 0.00% 0 | | + Medicine, Biopharma, Cancer fight
| + My List |
| SPRO | | Spero Therapeutics, Inc. - Common Stock | | | -11.11% -11.11% 0 | | + Disease: Infectious, Biopharma, Medicine
| + My List |
| TCON | | TRACON Pharmaceuticals, Inc. - Common Stock | | | -1.54% down 13.53% -15.07 | | + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology
| + My List |
| THTX | | Theratechnologies Inc. - Common Shares | | | 4.82% down 7.26% -2.44 | | + Cancer fight, Biopharma, Medicine
| + My List |
| TLRY | | Tilray, Inc. - Class 2 Common Stock | | | 4.47% down 7.17% -2.7 | | + Biopharma, Cannabis, Medicine, Country: Canada, Reddit's Wave
Last highlighted: #TLRY SEC report: Tilray, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Tilray, Inc. -- SEC File Number | + My List |
| TNXP | | Tonix Pharmaceuticals Holding Corp. - Common Stock | | | -9.91% -9.91% 0 | | + Medicine, Biopharma, Immunology, Disease: Addictions, Disease: Neurology/Alzheimer/Parkinson's, Disease: Central nervous system (CNS)
Last highlighted: $TNXP TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure https://t.co/hFCRf3OmpX | + My List |
| TRVN | | Trevena, Inc. - Common Stock | | | 0 | | + Biopharma, Medicine, Disease: Central nervous system (CNS)
Last highlighted: $TRVN Trading is easy with Buy and Short signals displayed on the chart https://t.co/optkvg9qmr | + My List |
| TTNP | | Titan Pharmaceuticals, Inc. - Common Stock | | | 0 | | + Biopharma, Disease: Central nervous system (CNS), Medicine
| + My List |
| VBLT | | Vascular Biogenics Ltd. - Ordinary Shares | | | 9.22% 9.22% 0 | | + Country: Israel, Biopharma, Cancer fight, Medicine
| + My List |
| VCEL | | Vericel Corporation - Common Stock | | | 2.72% down 7.47% -4.75 | | + Biopharma, Medicine, Sport
| + My List |
| VSTM | | Verastem, Inc. - Common Stock | | | 9.26% 9.26% 0 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620 | + My List |
| WINT | | Windtree Therapeutics, Inc. - Common Stock | | | up -38.85% 38.85 | | + Biopharma, Respiratory therapies / Pulmanory, Medicine
| + My List |
| XAIR | | Beyond Air, Inc. - Common Stock | | | -1.14% up -15.76% 14.62 | | + Respiratory therapies / Pulmanory, Medicine, Biopharma
| + My List |
| XBIO | | Xenetic Biosciences, Inc. - Common Stock | | | 0 | | + Biopharma, Cancer fight, Disease: Oncology, Medicine
| + My List |
| YMAB | | Y-mAbs Therapeutics, Inc. - Common Stock | | | -3.74% down 13.19% -16.93 | | + Biopharma, Cancer fight, Medicine
Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421 | + My List |
| ZSAN | | Zosano Pharma Corporation - Common Stock | | | 7.61% 7.61% 0 | | + Biopharma, Medicine
| + My List |
| GTBP | | GT Biopharma, Inc. - Common Stock | | | 15.42% 15.42% 0 | | + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight
Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131 | + My List |
| LABP | | Landos Biopharma, Inc. - Common Stock | | | -22.33% -22.33% 0 | | + Biopharma, Medicine
| + My List |
| LEXX | | Lexaria Bioscience Corp. - Common Stock | | | -2.82% up -9.19% 6.37 | | + Biopharma, Medicine, Cannabinoid-based
Last highlighted: #LEXX SEC report: Lexaria Bioscience Corp. Current report, item 8.01 | + My List |
| MASS | | 908 Devices Inc. - Common Stock | | | -6.34% down 18.27% -24.61 | | + Devices, Biopharma, Life Sciences
Last highlighted: #MASS SEC report: 908 Devices Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by 908 Devices Inc. -- SEC File Number 211142324 | + My List |
| SCPS | | Scopus BioPharma Inc. - Common Stock | | | 0 | | + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma
Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB | + My List |
| TERN | | Terns Pharmaceuticals, Inc. - Common Stock | | | 5.23% 5.23% 0 | | + Biopharma, Pharmaceutical , Disease: Liver
Last highlighted: $TERN 8-K Terns Pharmaceuticals (14 Jun, 4:40pm)
📰 Terns Reports Positive Top-line Results from Phase 2a LIFT Study of FXR Agonist TERN-101 in Patients with NASH
https://t.co/wJNwFxLOZw
#TERN #8K #TernsPharmaceuticals #News | + My List |
| TVTX | | Travere Therapeutics, Inc. - Common Stock | | | -14.97% down -14.76% -0.21 | | + Biopharma, Medicine
| + My List |
| VINC | | Vincerx Pharma, Inc. - Common Stock | | | -5.19% up -7.33% 2.14 | | + Biopharma, Medicine, Life Sciences
| + My List |
| VOR | | Vor Biopharma Inc. - Common Stock | | | -4.3% up -7.25% 2.95 | | + Biopharma, Medicine, Cancer fight, Disease: Oncology
| + My List |
| CNTB | | Connect Biopharma Holdings Limited - American Depositary Shares | | | 0 | | + Biopharma, Country: China, T cell-based
Last highlighted: $CNTB 6-K Connect Biopharma (16 Jun, 4:01pm)
📰 Current report (foreign)
https://t.co/U5Q30mPOFH
#CNTB #6K #ConnectBiopharma #News | + My List |
| OLK | | Olink Holding AB (publ) - American Depositary Shares | | | 6.18% down 7.05% -0.87 | | + Biology, Biopharma, Medicine, Country: Sweden
Last highlighted: #OLK SEC report: Olink Holding AB Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Olink Holding AB -- SEC File Number 211161931 | + My List |